These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 22500372)

  • 1. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular manifestations in Behçet's disease].
    Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
    Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
    Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye and Behçet's disease.
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.
    Sota J; Cantarini L; Vitale A; Sgheri A; Gentileschi S; Caggiano V; Gelardi V; Frediani B; Tosi GM; Fabiani C
    Mediators Inflamm; 2020; 2020():6872402. PubMed ID: 32508524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of patients with Behcet's uveitis].
    Liu XS; Gao F; Zhao C; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients.
    Barroso-García N; Atienza-Mateo B; Ferraz-Amaro I; Prieto-Peña D; Beltrán E; Adán A; Hernández-Garfella M; Martínez-Costa L; Cordero-Coma M; Díaz-Llopis M; Herreras JM; Maíz-Alonso O; Torre-Salaberri I; De Vicente-Delmás A; Díaz-Valle D; Atanes-Sandoval A; Francisco F; Insua S; Sánchez J; Almodóvar-González R; Jiménez-Sosa A; Ruiz-Moreno O; Gandía-Martínez M; Nolla JM; Calvo-Río V; Castañeda S; González-Gay MA; Blanco R
    Semin Arthritis Rheum; 2023 Feb; 58():152153. PubMed ID: 36549244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet's Uveitis.
    Tao T; He D; Peng X; Huang Z; Su W
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1897-1900. PubMed ID: 37801670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
    Barešić M; Reihl M; Habek M; Vukojević N; Anić B
    Rheumatol Int; 2018 Jul; 38(7):1301-1306. PubMed ID: 29777341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
    Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
    Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet's uveitis with vasculitis.
    Yang S; Huang Z; Liu X; Li H; Xie L; Chen X; Wen F; Liang D; Su W
    Int Immunopharmacol; 2021 Apr; 93():107430. PubMed ID: 33581500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
    Amer R; Alsughayyar W; Almeida D
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of Behçet's disease in the Indian population.
    Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
    Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
    Davatchi F; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Sadeghi Abdollahi B; Faezi T; Akhlaghi M; Ashofteh F
    Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eye and Behçet's disease].
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.